BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, January 17, 2026
Home » Topics » Briefs » Other news to note

Other news to note
Other news to note RSS Feed RSS

Other news to note for April 15, 2025

April 15, 2025
Biopharma happenings in Asia-Pacific including deals and partnerships, grants, preclinical data and other news in brief: Avernus, Evenus, Fresenius Kabi, Hengrui, Kalvista, Kaken, Oncozenge, Opthea, Pacira.
Read More

Other news to note for April 14, 2025

April 14, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Carmat, Elutia, Sequana Medical, Vicarious Surgical.
Read More

Other news to note for April 14, 2025

April 14, 2025
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Avernus, Opthea, Oncozenge.
Read More

Other news to note for April 11, 2025

April 11, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Basel Medical Group, Biosymetrics, Bethesda Medical, Cagent Vascular, Daxor, Green Earth Biomedical, Keensight Capital, Motion Informatics, Niox.
Read More

Other news to note for April 11, 2025

April 11, 2025
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Atossa, Keros, Nona, Revive, Tempest, Tevogen, Torpedo.
Read More

Other news to note for April 10, 2025

April 10, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Chemeleon, Drummond, GE Healthcare, Innoblative, Nextech, Ocuco, Ondine, Prapela.
Read More

Other news to note for April 10, 2025

April 10, 2025
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Advaxis, Ayala, Biosymetrics, Makana, OS Therapies, QumulusAI, Renovaro, Tonix, Vincerx.
Read More

Other news to note for April 10, 2025

April 10, 2025
Additional early-stage research and drug discovery news in brief, from: Rondo Therapeutics.
Read More

Other news to note for April 9, 2025

April 9, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Baird, Cepheid, Danaher, Nyxoah, Oxford Nanopore, Paige, Sectra, Shine.
Read More

Other news to note for April 9, 2025

April 9, 2025
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Defence, Evenus, Fresenius Kabi, Hengrui, Kaken, Kalvista, Ocuvex, Onconetix, Pacira, Synthego, Vita.
Read More
Previous 1 2 … 42 43 44 45 46 47 48 49 50 … 1386 1387 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 16, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 16, 2026.
  • SERPINB1 as potential biomarker for spinocerebellar ataxia type 2

    BioWorld Science
    Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
  • Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal

    BioWorld
    With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
  • Businesswoman pressing dollar sign on touchscreen

    JPM 2026: Year kicks off with biopharma Q4 revenue and guidance

    BioWorld
    It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing